-
Play video Webinar: No patient left behind: N-of-1 trial challenges and solutions in rare disease clinical development
Webinar: No patient left behind: N-of-1 trial challenges and solutions in rare disease clinical development
1:22:12
-
Play video Webinar: Considerations for Oligonucleotide Therapeutics in CMC
Webinar: Considerations for Oligonucleotide Therapeutics in CMC
1:01:14
-
Play video Webinar Panel: Women's Health
Webinar Panel: Women's Health
29:01
-
Play video Webinar_The Cell Therapy Product Journey
Webinar_The Cell Therapy Product Journey
1:41:50
-
Play video ICON World Children’s Day
ICON World Children’s Day
1:00:35
-
Play video Pediatric considerations for the development of medicines
Pediatric considerations for the development of medicines
1:33:44
-
Play video Best practices in accessible clinical trial design
Best practices in accessible clinical trial design
1:00:08
-
Play video Not all measures matter: How to identify outcomes measures appropriate for your rare disease patient populations
Not all measures matter: How to identify outcomes measures appropriate for your rare disease patient populations
1:02:01
-
Play video Unique considerations around accessibility for global clinical trials
Unique considerations around accessibility for global clinical trials
1:02:00
-
Play video Meeting trial participants where they’re at: Where DCTs can help achieve greater accessibility
Meeting trial participants where they’re at: Where DCTs can help achieve greater accessibility
59:57
-
Play video Accessibility in rare disease paediatric clinical trials
Accessibility in rare disease paediatric clinical trials
1:00:15
-
Play video Where do expanded access programmes fit into trial accessibility?
Where do expanded access programmes fit into trial accessibility?
59:43
- Load More